Dental treatment in patients with hereditary coagulopathy: hemophilia and Von Willebrand's disease




Hemophilia; Blood coagulation; Dental care.


Coagulopathy is defined as a “bleeding disease”, resulting from the quantitative and/or qualitative deficiency of one or more plasma proteins (coagulation factors). The common characteristic of hereditary coagulopathies is the reduction in the formation of thrombin, an essential factor for blood clotting. In this sense, this research has the objective of carrying out a literature review about the dental procedures that can be routinely performed in patients with hereditary coagulopathy. For the construction of this work, a bibliographical survey was carried out in the databases SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect, using the Mendeley reference manager. Bleeding disorders have been of great concern to healthcare professionals, including dentists, for some time. Hemophilia is the most common bleeding disorder, affecting 1 in 10,000 people worldwide. Oral health is often neglected by hemophiliacs for fear of bleeding during procedures, and the wealthy population is no exception. Early dental care is of paramount importance in these patients to avoid invasive procedures in the future. A thorough understanding of the problems, especially hemophilia, helps the dentist to carry out a systematic assessment and anticipate potential dangers, rather than being caught off guard with sparse and desperate local hemostatic measures.


Abed, H., & Abdalrahman A. (2017). “Dental Management of Patients with Inherited Bleeding Disorders: A Multidisciplinary Approach.” General Dentistry 65(6):56–60.

Baykul, T., E. Guchan A., & Gulperi K. 2010. “Use of Ankaferd Blood Stopper as a Hemostatic Agent: A Clinical Experience.” The Journal of Contemporary Dental Practice 11(1):E088-94.

van Dijk, Wobke E. M., Robert J. J. van Es, Maria E. P. Correa, Roger E. G. Schutgens, and Karin P. M. van Galen. (2021). “Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline.” TH Open : Companion Journal to Thrombosis and Haemostasis 5(4):e489–502. 10.1055/a-1641-7770.

Fleming, P. S. (2015). “Multi-Disciplinary Management to Align Ectopic or Impacted Teeth.” Seminars in Orthodontics 21(1):38–45.

Franchini, M., G. Rossetti, A. Tagliaferri, C. Pattacini, D. Pozzoli, C. Lorenz, L. Del Dot, G. Ugolotti, C. Dell’aringa, & G. Gandini. 2005. “Dental Procedures in Adult Patients with Hereditary Bleeding Disorders: 10 Years Experience in Three Italian Hemophilia Centers.” Haemophilia : The Official Journal of the World Federation of Hemophilia 11(5):504–9. 10.1111/j.1365-2516.2005.01132.x.

van Galen, Karin P. M., Eveline T. Engelen, Evelien P. Mauser-Bunschoten, Robert J. J. van Es, & Roger E. G. Schutgens. 2015. “Antifibrinolytic Therapy for Preventing Oral Bleeding in Patients with Haemophilia or Von Willebrand Disease Undergoing Minor Oral Surgery or Dental Extractions.” The Cochrane Database of Systematic Reviews (12):CD011385. 10.1002/14651858.CD011385.pub2.

Gupta, A., Joel B. E., & Robert J. C. (2007). “Bleeding Disorders of Importance in Dental Care and Related Patient Management.” Journal (Canadian Dental Association) 73(1):77–83.

Israels, S., Nora S., Ron B., & Archie M. (2006). “Bleeding Disorders: Characterization, Dental Considerations and Management.” Journal (Canadian Dental Association) 72(9):827.

Kumar, R., & Manuel C. (2013). “Inherited Abnormalities of Coagulation: Hemophilia, von Willebrand Disease, and Beyond.” Pediatric Clinics of North America 60(6):1419–41. 10.1016/j.pcl.2013.09.002.

Levy, Jerrold H., & Kenichi A. T. (2008). “Management of Surgical Hemostasis: Systemic Agents.” Vascular 16 Suppl 1:S14-21.

Rodriguez-Merchan, E. C. (2010). “Musculoskeletal Complications of Hemophilia.” HSS Journal : The Musculoskeletal Journal of Hospital for Special Surgery 6(1):37–42. 10.1007/s11420-009-9140-9.

Rogaev, Evgeny I., Anastasia P. Grigorenko, Gulnaz Faskhutdinova, Ellen L. W. Kittler, & Yuri K. M. (2009) “Genotype Analysis Identifies the Cause of the ‘Royal Disease.’” Science 326(5954):817. 10.1126/science.1180660.

Römer, P., et al., (2022) “Bleeding Disorders in Implant Dentistry: A Narrative Review and a Treatment Guide.” International Journal of Implant Dentistry 8(1):20. 10.1186/s40729-022-00418-2.

Shastry, S. P., Rachna K., Kusai B., & Dilshad U. (2014). “Hemophilia A: Dental Considerations and Management.” Journal of International Society of Preventive & Community Dentistry 4(Suppl 3):S147-52. 10.4103/2231-0762.149022.

Srivastava, A., A. K. Brewer, E. P. Mauser-Bunschoten, N. S. Key, S. Kitchen, A. Llinas, C. A. Ludlam, J. N. Mahlangu, K. Mulder, M. C. & Poon, A. S (2013). “Guidelines for the Management of Hemophilia.” Haemophilia : The Official Journal of the World Federation of Hemophilia 19(1):e1-47. 10.1111/j.1365-2516.2012.02909.x.

Tobelem, G., & C. Rothschild. (1982) “The factor VIII complex: hemophilia A and von Willebrand disease.” La semaine des hopitaux : organe fonde par l’Association d’enseignement medical des hopitaux de Paris 58(35):2032–36.



How to Cite

OLIVEIRA NETO, J. L. de .; AFONSO, Áquila de O.; CARNEIRO, G. K. M. .; GONÇALVES JÚNIOR, . H. de S. .; BRAGA , M. D. de S. .; DALLEPIANE, F. G. .; PEREIRA, A. de L. .; SENA, C. V. G. .; ARAÚJO, F. R. da C. .; LIMA, M. P. M. de . Dental treatment in patients with hereditary coagulopathy: hemophilia and Von Willebrand’s disease. Research, Society and Development, [S. l.], v. 12, n. 1, p. e7112136837, 2023. DOI: 10.33448/rsd-v12i1.36837. Disponível em: Acesso em: 27 jan. 2023.



Health Sciences